Foghorn Therapeutics FHTX Q2 2025 earnings
Reported August 5, 2025 · Before market open
Revenue$7.6MMiss by $616.0K
EPS-$0.28Beat by $0.03
Revenue estimate$8.2M
EPS estimate-$0.31
Next report
Aug 4, 2026 (In 6 days)Revenue estimate$7.0M
EPS estimate-$0.23
Versus estimates
Revenue
Diluted EPS
Ask the moment Foghorn Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Foghorn Therapeutics report Q2 2025 earnings?
- Foghorn Therapeutics (FHTX) reported Q2 2025 earnings on August 5, 2025 before market open.
- What were Foghorn Therapeutics's Q2 2025 revenue and EPS?
- Foghorn Therapeutics reported revenue of $7.6M and eps of $-0.28 for Q2 2025.
- Did Foghorn Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $8.2M by $616.0K. EPS beat the consensus estimate of $-0.31 by $0.03.
- How did Foghorn Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 9.7% from $6.9M a year earlier and eps grew 37.8% from $-0.45.
- Where can I find Foghorn Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-037606) directly on SEC EDGAR. The filing index links above go to sec.gov.